Using Electronic Health Records and Machine Learning to Predict Postpartum Depression. Wang Shuojia et al. Studies in health technology and informatics 2019 Aug 264888-892

Main|Search|PHGKB






Last Posted: Aug 27, 2019

---

• Using Electronic Health Records and Machine Learning to Predict Postpartum Depression.
  Wang Shuojia et al. Studies in health technology and informatics 2019 Aug 264888-892
• Development of Machine Learning Algorithms for Prediction of Sustained Postoperative Opioid Prescriptions After Total Hip Arthroplasty.
  Karhade Aditya V et al. The Journal of arthroplasty 2019 Jun
• Roadmap for Routine Pharmacogenetic Testing in a Psychiatric University Hospital.
  Menke Andreas et al. Pharmacopsychiatry 2019 Jun
• Where to Target? The Precision Medicine Approach to Brain Stimulation.
  McMullen David P et al. Biological psychiatry 2018 84(1) e1-e2
• Moving pharmacoepigenetics tools for depression toward clinical use.
  Hack Laura M et al. Journal of affective disorders 2019 Feb 249336-346
• Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study.
  Perlis Roy H et al. Depression and anxiety 2018 35(10) 946-952
• An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care.
  Sluiter Reinier L et al. The pharmacogenomics journal 2019 Jan
• Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?
  Solomon Haley V et al. Psychiatry research 2018 Dec 271604-613
• Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
  Chang Donald D et al. Pharmacogenomics 2018 Nov 19(16) 1269-1284
• Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder.
  Groessl Erik J et al. Journal of managed care & specialty pharmacy 2018 Aug 24(8) 726-734

more